Compare Invesco S&P 500 Momentum ETF (SPMO) vs GeneDx Holdings Corp (WGS) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Invesco S&P 500 Momentum ETF vs GeneDx Holdings Corp — how do they compare? Invesco S&P 500 Momentum ETF trades at $150.7, while GeneDx Holdings Corp trades at $82.5 (market cap $2.44B). The key difference: Invesco S&P 500 Momentum ETF is trading nearer its 52-week high, GeneDx Holdings Corp nearer its low. Which is the better fit depends on your goals.
| SPMO | WGS | |
|---|---|---|
Sector | Broad Market / Factor | Technology |
52-Week High | $161.66 | $167.51 |
52-Week Low | $107.84 | $34.51 |
Market Cap | — | $2.44B |
Enterprise Value | — | $2.48B |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Invesco S&P 500 Momentum ETF
SPMO is designed to track the investment results of the S&P 500 Momentum Index. This index measures the performance of stocks in the S&P 500 that exhibit the highest momentum, or the greatest price appreciation, over the trailing 12 months, while excluding the most recent month. By investing in these high-momentum stocks, SPMO seeks to capitalize on the historical trend that stocks with strong recent performance tend to continue that performance in the near term, offering a systematic approach to factor investing within the large-cap U.S. equity market.
Read more on SPMO →About GeneDx Holdings Corp
GeneDx is a patient-centered health intelligence company that specializes in transforming healthcare through the application of genomics. It combines advanced technology with one of the world's largest rare disease genomic datasets to provide clinical-grade exome and genome sequencing, enabling precise and rapid diagnosis for patients with complex medical conditions.
Read more on WGS →
